Lupus & antiphospholipid syndrome
ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations
Methodological detailsinternational taskforce, multistep process
- International taskforce
- Multistep process
Recommendations
As issued by the authors
Systemic lupus erythematosus (SLE) enteritis and pancreatitis: HCQ, GC, and CYC or MMF.
Rare lung conditions such as pneumonitis: CYC if severe, MMF if not severe.
Myocarditis: HCQ, GC, and CYC or MMF, based on severity.
CNS manifestations: HCQ, GC, and CYC or MMF were common choices.
Rare skin manifestations: preferred HCQ plus GC with anifrolumab or MMF.
Original publication
ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations. Lancet Rheumatol. Published 23 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →